Keratin 16 regulates innate immunity in response to epidermal barrier breach

Proceedings of the National Academy of Sciences of the United States of America

Volumn 110, Issue 48, 2013, Pages 19537-19542

  Lessard, Juliane C ^a   Piña Paz, Sylvia ^a   Rotty, Jeremy D ^a   Hickerson, Robyn P ^b   Kaspar, Roger L ^b,c   Balmain, Allan ^d   Coulombe, Pierre A ^a,e  

^a JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^b TransDerm Inc   (United States)

^c STANFORD UNIVERSITY   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Epidermis; Intermediate filament

Indexed keywords

CYTOKERATIN 16; CYTOKERATIN 17; FILAGGRIN;

ANIMAL EXPERIMENT; ARTICLE; CALLUS; CD4+ T LYMPHOCYTE; CELL PROLIFERATION; CONGENITAL PACHYONYCHIA; CONTROLLED STUDY; EPIDERMIS; GENE EXPRESSION; GENE MUTATION; GENETIC ASSOCIATION; GENETIC TRANSCRIPTION; GLABROUS SKIN; HUMAN; INFLAMMATION; INNATE IMMUNITY; MONOCYTE; MOUSE; NEUTROPHIL; NONHUMAN; PALMOPLANTAR KERATODERMA; PRIORITY JOURNAL; STRATUM CORNEUM; WOUND HEALING;

EPIDERMIS; INTERMEDIATE FILAMENT;

ANIMALS; BLOTTING, WESTERN; DNA PRIMERS; GENE EXPRESSION PROFILING; GENE REGULATORY NETWORKS; HUMANS; IMMUNITY, INNATE; KERATIN-16; KERATIN-6; MICE; MICROARRAY ANALYSIS; MICROSCOPY, ELECTRON, TRANSMISSION; PACHYONYCHIA CONGENITA; REAL-TIME POLYMERASE CHAIN REACTION;

EID: 84888354152     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1309576110     Document Type: Article

References (66)

1. Nestle FO, Di Meglio P, Qin JZ, Nickoloff BJ (2009) Skin immune sentinels in health and disease. Nat Rev Immunol 9(10): 679-691.
2. Bianchi ME (2007) DAMPs, PAMPs and alarmins: All we need to know about danger. J Leukoc Biol 81(1): 1-5.
3. Eckert RL, et al. (2004) S100 proteins in the epidermis. J Invest Dermatol 123(1): 23-33.
4. Oppenheim JJ, Yang D (2005) Alarmins: Chemotactic activators of immune responses. Curr Opin Immunol 17(4): 359-365.
5. Lai Y, Gallo RL (2009) AMPed up immunity: How antimicrobial peptides have multiple roles in immune defense. Trends Immunol 30(3): 131-141.
6. Ehrchen JM, Sunderkötter C, Foell D, Vogl T, Roth J (2009) The endogenous Toll-like receptor 4 agonist S100A8/S100A9 (calprotectin) as innate amplifier of infection, autoimmunity, and cancer. J Leukoc Biol 86(3): 557-566.
7. DePianto D, Coulombe PA (2004) Intermediate filaments and tissue repair. Exp Cell Res 301(1): 68-76.
8. Rotty JD, Coulombe PA (2012) A wound-induced keratin inhibits Src activity during keratinocyte migration and tissue repair. J Cell Biol 197(3): 381-389.
9. Tong X, Coulombe PA (2006) Keratin 17 modulates hair follicle cycling in a TNFalphadependent fashion. Genes Dev 20(10): 1353-1364.
10. Kim S, Wong P, Coulombe PA (2006) A keratin cytoskeletal protein regulates protein synthesis and epithelial cell growth. Nature 441(7091): 362-365.
11. Depianto D, Kerns ML, Dlugosz AA, Coulombe PA (2010) Keratin 17 promotes epithelial proliferation and tumor growth by polarizing the immune response in skin. Nat Genet 42(10): 910-914.
12. Haider AS, et al. (2006) Genomic analysis defines a cancer-specific gene expression signature for human squamous cell carcinoma and distinguishes malignant hyperproliferation from benign hyperplasia. J Invest Dermatol 126(4): 869-881.
13. Leachman SA, et al. (2005) Clinical and pathological features of pachyonychia congenita. J Investig Dermatol Symp Proc 10(1): 3-17.
14. Lessard JC, Coulombe PA (2012) Keratin 16-null mice develop palmoplantar keratoderma, a hallmark feature of pachyonychia congenita and related disorders. J Invest Dermatol 132(5): 1384-1391.
15. Cooper L, Johnson C, Burslem F, Martin P (2005) Wound healing and inflammation genes revealed by array analysis of 'macrophageless' PU.1 null mice. Genome Biol 6(1):R5.
16. Deonarine K, et al. (2007) Gene expression profiling of cutaneous wound healing. J Transl Med 5:11.
17. Roy S, Khanna S, Rink C, Biswas S, Sen CK (2008) Characterization of the acute temporal changes in excisional murine cutaneous wound inflammation by screening of the wound-edge transcriptome. Physiol Genomics 34(2): 162-184.
18. Lee P, et al. (2009) Dynamic expression of epidermal caspase 8 simulates a wound healing response. Nature 458(7237): 519-523.
19. Paladini RD, Takahashi K, Bravo NS, Coulombe PA (1996) Onset of re-epithelialization after skin injury correlates with a reorganization of keratin filaments in wound edge keratinocytes: Defining a potential role for keratin 16. J Cell Biol 132(3): 381-397.
20. Quigley DA, et al. (2009) Genetic architecture of mouse skin inflammation and tumour susceptibility. Nature 458(7237): 505-508.
21. Vermeij WP, Backendorf C (2010) Skin cornification proteins provide global link between ROS detoxification and cell migration during wound healing. PLoS ONE 5(8):e11957.
22. Schäfer M, et al. (2012) Nrf2 links epidermal barrier function with antioxidant defense. EMBO Mol Med 4(5): 364-379.
23. Hawley-Nelson P, Roop DR, Cheng CK, Krieg TM, Yuspa SH (1988) Molecular cloning of mouse epidermal cystatin A and detection of regulated expression in differentiation and tumorigenesis. Mol Carcinog 1(3): 202-211.
24. Gariboldi M, et al. (2003) SCCA2-like serpins mediate genetic predisposition to skin tumors. Cancer Res 63(8): 1871-1875.
25. Takahashi K, Yan B, Yamanishi K, Imamura S, Coulombe PA (1998) The two functional keratin 6 genes of mouse are differentially regulated and evolved independently from their human orthologs. Genomics 53(2): 170-183.
26. Tam C, Mun JJ, Evans DJ, Fleiszig SM (2012) Cytokeratins mediate epithelial innate defense through their antimicrobial properties. J Clin Invest 122(10): 3665-3677.
27. Mueller MM (2006) Inflammation in epithelial skin tumours: Old stories and new ideas. Eur J Cancer 42(6): 735-744.
28. Kopan R, Fuchs E (1989) The use of retinoic acid to probe the relation between hyperproliferation- associated keratins and cell proliferation in normal and malignant epidermal cells. J Cell Biol 109(1): 295-307.
29. Feldmeyer L, et al. (2007) The inflammasome mediates UVB-induced activation and secretion of interleukin-1beta by keratinocytes. Curr Biol 17(13): 1140-1145.
30. Roth W, et al. (2012) Keratin 1 maintains skin integrity and participates in an inflammatory network in skin through interleukin-18. J Cell Sci 125(Pt 22): 5269-5279.
31. Lu H, et al. (2007) Induction of inflammatory cytokines by a keratin mutation and their repression by a small molecule in a mouse model for EBS. J Invest Dermatol 127(12): 2781-2789.
32. Wood LC, Jackson SM, Elias PM, Grunfeld C, Feingold KR (1992) Cutaneous barrier perturbation stimulates cytokine production in the epidermis of mice. J Clin Invest 90(2): 482-487.
33. Nickoloff BJ, Naidu Y (1994) Perturbation of epidermal barrier function correlates with initiation of cytokine cascade in human skin. J Am Acad Dermatol 30(4): 535-546.
34. Harder J, et al. (2010) Enhanced expression and secretion of antimicrobial peptides in atopic dermatitis and after superficial skin injury. J Invest Dermatol 130(5): 1355-1364.
35. Yoo J, et al. (2005) Spontaneous atopic dermatitis in mice expressing an inducible thymic stromal lymphopoietin transgene specifically in the skin. J Exp Med 202(4): 541-549.
36. Wolf R, et al. (2010) Gene from a psoriasis susceptibility locus primes the skin for inflammation. Sci Transl Med 2(61):61ra90.
37. Freedberg IM, Tomic-Canic M, Komine M, Blumenberg M (2001) Keratins and the keratinocyte activation cycle. J Invest Dermatol 116(5): 633-640.
38. Seltmann K, et al. (2013) Keratins mediate localization of hemidesmosomes and repress cell motility. J Invest Dermatol 133(1): 181-190.
39. Reichelt J (2007) Mechanotransduction of keratinocytes in culture and in the epidermis. Eur J Cell Biol 86(11-12): 807-816.
40. Watt FM (2002) Role of integrins in regulating epidermal adhesion, growth and differentiation. EMBO J 21(15): 3919-3926.
41. Pedersen E, et al. (2012) RAC1 in keratinocytes regulates crosstalk to immune cells by Arp2/3-dependent control of STAT1. J Cell Sci 125(Pt 22): 5379-5390.
42. Hobbs RM, Watt FM (2003) Regulation of interleukin-1alpha expression by integrins and epidermal growth factor receptor in keratinocytes from a mouse model of inflammatory skin disease. J Biol Chem 278(22): 19798-19807.
43. Hobbs RM, Silva-Vargas V, Groves R, Watt FM (2004) Expression of activated MEK1 in differentiating epidermal cells is sufficient to generate hyperproliferative and inflammatory skin lesions. J Invest Dermatol 123(3): 503-515.
44. Wong VW, Akaishi S, Longaker MT, Gurtner GC (2011) Pushing back: Wound mechanotransduction in repair and regeneration. J Invest Dermatol 131(11): 2186-2196.
45. Wong VW, et al. (2012) Focal adhesion kinase links mechanical force to skin fibrosis via inflammatory signaling. Nat Med 18(1): 148-152.
46. Kyriakis JM, Avruch J (2012) Mammalian MAPK signal transduction pathways activated by stress and inflammation: A 10-year update. Physiol Rev 92(2): 689-737.
47. Wang YN, Chang WC (2003) Induction of disease-associated keratin 16 gene expression by epidermal growth factor is regulated through cooperation of transcription factors Sp1 and c-Jun. J Biol Chem 278(46): 45848-45857.
48. Wang YN, Chen YJ, Chang WC (2006) Activation of extracellular signal-regulated kinase signaling by epidermal growth factor mediates c-Jun activation and p300 recruitment in keratin 16 gene expression. Mol Pharmacol 69(1): 85-98.
49. Chen YJ, Wang YN, Chang WC (2007) ERK2-mediated C-terminal serine phosphorylation of p300 is vital to the regulation of epidermal growth factor-induced keratin 16 gene expression. J Biol Chem 282(37): 27215-27228.
50. Kerns M, DePianto D, Yamamoto M, Coulombe PA (2010) Differential modulation of keratin expression by sulforaphane occurs via Nrf2-dependent and -independent pathways in skin epithelia. Mol Biol Cell 21(23): 4068-4075.
51. Paladini RD, Coulombe PA (1998) Directed expression of keratin 16 to the progenitor basal cells of transgenic mouse skin delays skin maturation. J Cell Biol 142(4): 1035-1051.
52. Sykiotis GP, Bohmann D (2010) Stress-activated cap'n'collar transcription factors in aging and human disease. Sci Signal 3(112):re3.
53. Endo H, Sugioka Y, Nakagi Y, Saijo Y, Yoshida T (2008) A novel role of the NRF2 transcription factor in the regulation of arsenite-mediated keratin 16 gene expression in human keratinocytes. Environ Health Perspect 116(7): 873-879.
54. auf dem Keller U, et al. (2006) Nrf transcription factors in keratinocytes are essential for skin tumor prevention but not for wound healing. Mol Cell Biol 26(10): 3773-3784.
55. DeNicola GM, et al. (2011) Oncogene-induced Nrf2 transcription promotes ROS detoxification and tumorigenesis. Nature 475(7354): 106-109.
56. Huebner AJ, et al. (2012) Amniotic fluid activates the nrf2/keap1 pathway to repair an epidermal barrier defect in utero. Dev Cell 23(6): 1238-1246.
57. Wu C, Li C, Wei L, Zheng Z (2008) Innate immune modulation of keratinocytes by antikeratin 16 antibodies. Exp Dermatol 17(8): 645-652.
58. Wu C, Luan Q, Li C, Zheng Z (2009) Effects of antikeratin 16 antibodies on the expression of Toll-like receptors 2 and 4 in keratinocytes. Clin Exp Dermatol 34(2): 236-239.
59. Mee JB, Johnson CM, Morar N, Burslem F, Groves RW (2007) The psoriatic transcriptome closely resembles that induced by interleukin-1 in cultured keratinocytes: Dominance of innate immune responses in psoriasis. Am J Pathol 171(1): 32-42.
60. Goldberg I, Fruchter D, Meilick A, Schwartz ME, Sprecher E (2013) Best treatment practices for pachyonychia congenita. J Eur Acad Dermatol Venereol, in press.
61. Leachman SA, et al. (2010) First-in-human mutation-targeted siRNA phase Ib trial of an inherited skin disorder. Mol Ther 18(2): 442-446.
62. Milstone LM, et al. (2005) Treatment of pachyonychia congenita. J Investig Dermatol Symp Proc 10(1): 18-20.
63. Leslie Pedrioli DM, et al. (2012) Generic and personalized RNAi-based therapeutics for a dominant-negative epidermal fragility disorder. J Invest Dermatol 132(6): 1627-1635.
64. Patel S, Zirwas M, English JC III (2007) Acquired palmoplantar keratoderma. Am J Clin Dermatol 8(1): 1-11.
65. Gruber R, et al. (2012) An appraisal of oral retinoids in the treatment of pachyonychia congenita. J Am Acad Dermatol 66(6):e193-e199.
66. Zhao Y, Gartner U, Smith FJ, McLean WH (2011) Statins downregulate K6a promoter activity: A possible therapeutic avenue for pachyonychia congenita. J Invest Dermatol 131(5): 1045-1052.